These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32854363)

  • 1. Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials.
    Zhao J; Santino F; Giacomini D; Gentilucci L
    Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32854363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α
    Baiula M; Anselmi M; Musiani F; Ghidini A; Carbone J; Caligiana A; Maurizio A; Spampinato S; Gentilucci L
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?
    Rocha LA; Learmonth DA; Sousa RA; Salgado AJ
    Biotechnol Adv; 2018; 36(1):208-227. PubMed ID: 29155160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Role of RGD-Recognizing Integrins in Cancer.
    Nieberler M; Reuning U; Reichart F; Notni J; Wester HJ; Schwaiger M; Weinmüller M; Räder A; Steiger K; Kessler H
    Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28869579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Relevance of RGD-Integrin Subtype-Specific Ligands in Cancer.
    Sani S; Messe M; Fuchs Q; Pierrevelcin M; Laquerriere P; Entz-Werle N; Reita D; Etienne-Selloum N; Bruban V; Choulier L; Martin S; Dontenwill M
    Chembiochem; 2021 Apr; 22(7):1151-1160. PubMed ID: 33140906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating.
    Mas-Moruno C; Fraioli R; Rechenmacher F; Neubauer S; Kapp TG; Kessler H
    Angew Chem Int Ed Engl; 2016 Jun; 55(25):7048-67. PubMed ID: 27258759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides.
    Egorova EA; Nikitin MP
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD and other recognition sequences for integrins.
    Ruoslahti E
    Annu Rev Cell Dev Biol; 1996; 12():697-715. PubMed ID: 8970741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin targeted delivery of chemotherapeutics.
    Chen K; Chen X
    Theranostics; 2011 Feb; 1():189-200. PubMed ID: 21547159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine.
    Barker TH
    Biomaterials; 2011 Jun; 32(18):4211-4. PubMed ID: 21515169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrins in cell adhesion and signaling.
    Akiyama SK
    Hum Cell; 1996 Sep; 9(3):181-6. PubMed ID: 9183647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Targeting via Integrin Ligands.
    Marelli UK; Rechenmacher F; Sobahi TR; Mas-Moruno C; Kessler H
    Front Oncol; 2013 Aug; 3():222. PubMed ID: 24010121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell adhesion molecules for targeted drug delivery.
    Dunehoo AL; Anderson M; Majumdar S; Kobayashi N; Berkland C; Siahaan TJ
    J Pharm Sci; 2006 Sep; 95(9):1856-72. PubMed ID: 16850395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy.
    Wu PH; Opadele AE; Onodera Y; Nam JM
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional ligands that target cells displaying the alpha v beta3 integrin.
    Owen RM; Carlson CB; Xu J; Mowery P; Fasella E; Kiessling LL
    Chembiochem; 2007 Jan; 8(1):68-82. PubMed ID: 17154219
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.